Difficulty: Medium
Average Score: 73%
Practice
Which of the following cholinomimetics is indirect-acting?
Correct answer
B
Rationale
In the context of safety pharmacology across the lifespan, understanding the classification of cholinomimetics is crucial for safe and effective medication management. The correct answer to the question, "Which of the following cholinomimetics is indirect-acting?" is B) Edrophonium.
Edrophonium is an indirect-acting cholinomimetic because it acts by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine. By inhibiting this enzyme, edrophonium increases the levels of acetylcholine in the synaptic cleft, leading to increased cholinergic activity.
Now, let's discuss why the other options are incorrect:
A) Lobeline: Lobeline is a nicotinic receptor agonist and is not classified as an indirect-acting cholinomimetic.
C) Pilocarpine: Pilocarpine is a direct-acting cholinomimetic that acts by directly stimulating cholinergic receptors without affecting acetylcholinesterase activity.
D) Carbachol: Carbachol is also a direct-acting cholinomimetic that directly stimulates cholinergic receptors without inhibiting acetylcholinesterase.
Educationally, knowing the classification of cholinomimetics helps healthcare professionals make informed decisions about drug selection, dosing, and potential adverse effects. Understanding the mechanism of action of different cholinomimetics is essential to ensure patient safety and optimal therapeutic outcomes across various age groups.
Edrophonium is an indirect-acting cholinomimetic because it acts by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine. By inhibiting this enzyme, edrophonium increases the levels of acetylcholine in the synaptic cleft, leading to increased cholinergic activity.
Now, let's discuss why the other options are incorrect:
A) Lobeline: Lobeline is a nicotinic receptor agonist and is not classified as an indirect-acting cholinomimetic.
C) Pilocarpine: Pilocarpine is a direct-acting cholinomimetic that acts by directly stimulating cholinergic receptors without affecting acetylcholinesterase activity.
D) Carbachol: Carbachol is also a direct-acting cholinomimetic that directly stimulates cholinergic receptors without inhibiting acetylcholinesterase.
Educationally, knowing the classification of cholinomimetics helps healthcare professionals make informed decisions about drug selection, dosing, and potential adverse effects. Understanding the mechanism of action of different cholinomimetics is essential to ensure patient safety and optimal therapeutic outcomes across various age groups.